Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary A Wood

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|September 3, 2021
pepsickle rapidly and accurately predicts proteasomal cleavage sites for improved neoantigen identificationBenjamin R Weeder, Mary A Wood, Ellysia Li, et al.
Genome Medicine|April 2, 2020
Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survivalMary A Wood, Benjamin R Weeder, Julianne K David, et al.
Genome Biology|November 11, 2022
Retained introns in long RNA-seq reads are not reliably detected in sample-matched short readsJulianne K David, Sean K Maden, Mary A Wood, et al.
Bioinformatics (Oxford, England)|August 20, 2019
neoepiscope improves neoepitope prediction with multivariant phasingMary A Wood, Austin Nguyen, Adam J Struck, et al.
Ecology and Evolution|April 29, 2025
Enhanced Iteroparity Is a Correlated Response to Direct Selection on Blood Feeding in a MosquitoRudyard J Borowczak, Mary A Wood, William E Bradshaw, et al.
Journal of Virology|April 19, 2020
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2Austin Nguyen, Julianne K David, Sean K Maden, et al.
BMC Cancer|April 15, 2018
Population-level distribution and putative immunogenicity of cancer neoepitopesMary A Wood, Mayur Paralkar, Mihir P Paralkar, et al.
Pigment Cell & Melanoma Research|April 22, 2021
Genetic analysis of multiple primary melanomas arising within the boundaries of congenital nevi depigmentosaAllison M Fuiten, Reilly G Fankhauser, Darren J Smit, et al.
Nature|March 24, 2022
Androgen receptor activity in T cells limits checkpoint blockade efficacyXiangnan Guan, Fanny Polesso, Chaojie Wang, et al.
Journal for Immunotherapy of Cancer|July 4, 2020
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide aloneJulie N Graff, Tomasz M Beer, Joshi J Alumkal, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|September 3, 2021
pepsickle rapidly and accurately predicts proteasomal cleavage sites for improved neoantigen identificationBenjamin R Weeder, Mary A Wood, Ellysia Li, et al.
Genome Medicine|April 2, 2020
Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survivalMary A Wood, Benjamin R Weeder, Julianne K David, et al.
Genome Biology|November 11, 2022
Retained introns in long RNA-seq reads are not reliably detected in sample-matched short readsJulianne K David, Sean K Maden, Mary A Wood, et al.
Bioinformatics (Oxford, England)|August 20, 2019
neoepiscope improves neoepitope prediction with multivariant phasingMary A Wood, Austin Nguyen, Adam J Struck, et al.
Ecology and Evolution|April 29, 2025
Enhanced Iteroparity Is a Correlated Response to Direct Selection on Blood Feeding in a MosquitoRudyard J Borowczak, Mary A Wood, William E Bradshaw, et al.
Journal of Virology|April 19, 2020
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2Austin Nguyen, Julianne K David, Sean K Maden, et al.
BMC Cancer|April 15, 2018
Population-level distribution and putative immunogenicity of cancer neoepitopesMary A Wood, Mayur Paralkar, Mihir P Paralkar, et al.
Pigment Cell & Melanoma Research|April 22, 2021
Genetic analysis of multiple primary melanomas arising within the boundaries of congenital nevi depigmentosaAllison M Fuiten, Reilly G Fankhauser, Darren J Smit, et al.
Nature|March 24, 2022
Androgen receptor activity in T cells limits checkpoint blockade efficacyXiangnan Guan, Fanny Polesso, Chaojie Wang, et al.
Journal for Immunotherapy of Cancer|July 4, 2020
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide aloneJulie N Graff, Tomasz M Beer, Joshi J Alumkal, et al.
Pageof 1